These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3729361

  • 21. [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
    Abe T, Fukuoka T, Sato Y, Ito K, Sei M.
    Jpn J Antibiot; 2002 Dec; 55(6):827-43. PubMed ID: 12621736
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity of U-76,252 (CS-807), a new oral cephalosporin.
    Fass RJ, Helsel VL.
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1082-5. PubMed ID: 3190194
    [Abstract] [Full Text] [Related]

  • 23. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Jul; 14(1):63-74. PubMed ID: 2013211
    [Abstract] [Full Text] [Related]

  • 24. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    Diagn Microbiol Infect Dis; 1991 Jul; 14(1):45-52. PubMed ID: 2013210
    [Abstract] [Full Text] [Related]

  • 25. In-vitro activity of Ro-15-8074, a new oral cephalosporin.
    Peeters M, Piot P.
    J Antimicrob Chemother; 1985 Oct; 16(4):469-73. PubMed ID: 3877719
    [Abstract] [Full Text] [Related]

  • 26. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R, Andrews JM, Cross C, Piddock LJ.
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [Abstract] [Full Text] [Related]

  • 27. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of the two new oral cephalosporins RO 15-8074 and RO 19-5247.
    Stobberingh E, Houben AW, van Boven CP.
    Eur J Clin Microbiol; 1987 Aug; 6(4):489-90. PubMed ID: 3665902
    [No Abstract] [Full Text] [Related]

  • 29. Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin.
    Thomas MG, Lang SD.
    Antimicrob Agents Chemother; 1986 May; 29(5):945-7. PubMed ID: 3729354
    [Abstract] [Full Text] [Related]

  • 30. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium.
    Verbist L, Jacobs J, Hens K.
    Diagn Microbiol Infect Dis; 1991 May; 14(1):53-61. PubMed ID: 1901535
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
    Bowie WR, Shaw CE, Chan DG, Black WA.
    Antimicrob Agents Chemother; 1987 Mar; 31(3):470-2. PubMed ID: 2953304
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S.
    Drugs Exp Clin Res; 1989 Mar; 15(1):1-10. PubMed ID: 2663406
    [Abstract] [Full Text] [Related]

  • 33. Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.
    Angehrn P, Probst PJ, Reiner R, Then RL.
    Antimicrob Agents Chemother; 1980 Dec; 18(6):913-21. PubMed ID: 6972194
    [Abstract] [Full Text] [Related]

  • 34. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
    Neu HC.
    Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of BMY-28100, a new oral cephalosporin.
    Eliopoulos GM, Reiszner E, Wennersten C, Moellering RC.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):653-6. PubMed ID: 3496846
    [Abstract] [Full Text] [Related]

  • 36. Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
    Neu HC, Chin NX, Labthavikul P.
    Antimicrob Agents Chemother; 1984 Aug; 26(2):174-80. PubMed ID: 6333207
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of Ro 09-1428 compared to other cephalosporins.
    Chin NX, Gu JW, Fang W, Neu HC.
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):669-75. PubMed ID: 1748124
    [Abstract] [Full Text] [Related]

  • 38. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [Abstract] [Full Text] [Related]

  • 39. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO, Bryskier A, Izard D, Leclerc H.
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [Abstract] [Full Text] [Related]

  • 40. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F, Baquero F.
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.